The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Nonhistone protein acetylation as cancer therapy targets
Open accessAbstract
Acetylation and deacetylation are counteracting, post-translational modifications that affect a large number of histone and nonhistone proteins. The significance of histone acetylation in the modification of chromatin structure and dynamics, and thereby gene transcription regulation, has been well recognized. A steadily growing number of nonhistone proteins have been identified as acetylation targets and reversible lysine acetylation in these proteins plays an important role(s) in the regulation of mRNA stability, protein localization and degradation, and protein-protein and protein-DNA interactions. The recruitment of histone acetyltransferases (HATs) and histone deacetylases (HDACs) to the transcriptional machinery is a key element in the dynamic regulation of genes controlling cellular proliferation, differentiation and apoptosis. Many nonhistone proteins targeted by acetylation are the products of oncogenes or tumor-suppressor genes and are directly involved in tumorigenesis, tumor progression and metastasis. Aberrant activity of HDACs has been documented in several types of cancers and HDAC inhibitors (HDACi) have been employed for therapeutic purposes. Here we review the published literature in this field and provide updated information on the regulation and function of nonhistone protein acetylation. While concentrating on the molecular mechanism and pathways involved in the addition and removal of the acetyl moiety, therapeutic modalities of HDACi are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, C.-S., Wang, Y.-C., Yang, H.-C., Huang, P.-H., Kulp, S. K., Yang, C.-C., Lu, Y.-S., Matsuyama, S., Chen, C.-Y., & Chen, C.-S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3996 · Cited by 187
RetractedLysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,639
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
Histone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., & Verdin, E. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00038-8 · Cited by 1,536
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
Epigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,249
Shaping the nuclear action of NF-κB
Chen, L.-F., & Greene, W. C. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1368 · Cited by 1,221
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Calnan, D. R., & Brunet, A. (2008) · Oncogene · doi:10.1038/onc.2008.21 · Cited by 1,170
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
Yang, X.-J., & Seto, E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.07.002 · Cited by 1,006
Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.
Vaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.031 · Cited by 916
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB
Chen, L., Mu, Y., & Greene, W. C. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf660 · Cited by 827
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Histone Deacetylase 4 Controls Chondrocyte Hypertrophy during Skeletogenesis
Vega, R. B., Matsuda, K., Oh, J., Barbosa, A. C., Yang, X., Meadows, E., McAnally, J., Pomajzl, C., Shelton, J. M., Richardson, J. A., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.024 · Cited by 804
Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue
Yuan, Z.-L., Guan, Y.-J., Chatterjee, D., & Chin, Y. E. (2005) · Science · doi:10.1126/science.1105166 · Cited by 790
n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells
RIGGS, M. G., WHITTAKER, R. G., NEUMANN, J. R., & INGRAM, V. M. (1977) · Nature · doi:10.1038/268462a0 · Cited by 787
Bustin, M., & Reeves, R. (1996) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60360-8 · Cited by 763
Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression
Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2672 · Cited by 760
Piekarz, R. L., Frye, R., Turner, M., Wright, J. J., Allen, S. L., Kirschbaum, M. H., Zain, J., Prince, H. M., Leonard, J. P., Geskin, L. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6150 · Cited by 740
In vivo destabilization of dynamic microtubules by HDAC6‐mediated deacetylation
Matsuyama, A., Shimazu, T., Sumida, Y., Saito, A., Yoshimatsu, Y., Seigneurin‐Berny, D., Osada, H., Komatsu, Y., Nishino, N., Khochbin, S., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf682 · Cited by 720
Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J., & Kim, K.-W. (2002) · Cell · doi:10.1016/s0092-8674(02)01085-1 · Cited by 716
Histone deacetylase inhibitors: Potential in cancer therapy
Marks, P. A., & Xu, W. ‐. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22185 · Cited by 712
Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., & Berger, S. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00414-2 · Cited by 710
Regulation of E2F1 activity by acetylation
Martínez-Balbás, M. A., Bauer, U.-M., Nielsen, S. J., Brehm, A., & Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.662 · Cited by 671
Acetylation of non-histone proteins modulates cellular signalling at multiple levels
Spange, S., Wagner, T., Heinzel, T., & Krämer, O. H. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.027 · Cited by 664
Zhang, H. S., Gavin, M., Dahiya, A., Postigo, A. A., Ma, D., Luo, R. X., Harbour, J. W., & Dean, D. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80625-x · Cited by 658
Discovery and development of SAHA as an anticancer agent
Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210204 · Cited by 626
HMG1 and 2, and related ‘architectural’ DNA-binding proteins
Thomas, J. O., & Travers, A. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01801-1 · Cited by 618
Grozinger, C. M., & Schreiber, S. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140199597 · Cited by 588
Acetylation of the C Terminus of Ku70 by CBP and PCAF Controls Bax-Mediated Apoptosis
Cohen, H. Y., Lavu, S., Bitterman, K. J., Hekking, B., Imahiyerobo, T. A., Miller, C., Frye, R., Ploegh, H., Kessler, B. M., & Sinclair, D. A. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00094-2 · Cited by 578
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570
FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2
van der Horst, A., Tertoolen, L. G. J., de Vries-Smits, L. M. M., Frye, R. A., Medema, R. H., & Burgering, B. M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401138200 · Cited by 543
Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65
Kiernan, R., Brès, V., Ng, R. W. M., Coudart, M.-P., El Messaoudi, S., Sardet, C., Jin, D.-Y., Emiliani, S., & Benkirane, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209572200 · Cited by 535
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases
Yang, X.-J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh252 · Cited by 515
Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer
Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E., & Robson, C. N. (2004) · The Prostate · doi:10.1002/pros.20022 · Cited by 509
Ungerstedt, J. S., Sowa, Y., Xu, W.-S., Shao, Y., Dokmanovic, M., Perez, G., Ngo, L., Holmgren, A., Jiang, X., & Marks, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408732102 · Cited by 503
A Novel Mechanism of Chemoprotection by Sulforaphane
Myzak, M. C., Karplus, P. A., Chung, F.-L., & Dashwood, R. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1326 · Cited by 494
Sirtuins: critical regulators at the crossroads between cancer and aging
Saunders, L. R., & Verdin, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210616 · Cited by 489
Mechanism of active transcriptional repression by the retinoblastoma protein
Weintraub, S. J., Chow, K. N. B., Luo, R. X., Zhang, S. H., He, S., & Dean, D. C. (1995) · Nature · doi:10.1038/375812a0 · Cited by 487
Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation
Matsuzaki, H., Daitoku, H., Hatta, M., Aoyama, H., Yoshimochi, K., & Fukamizu, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502738102 · Cited by 481
Sirtuin Functions in Health and Disease
Yamamoto, H., Schoonjans, K., & Auwerx, J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0079 · Cited by 480
(2003) · PubMed · Cited by 465
Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?
Thomas, M. J., & Seto, E. (1999) · Gene · doi:10.1016/s0378-1119(99)00261-9 · Cited by 465
MEF2C Transcription Factor Controls Chondrocyte Hypertrophy and Bone Development
Arnold, M. A., Kim, Y., Czubryt, M. P., Phan, D., McAnally, J., Qi, X., Shelton, J. M., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.02.004 · Cited by 456
Murphy, M., Ahn, J., Walker, K. K., Hoffman, W. H., Evans, R. M., Levine, A. J., & George, D. L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2490 · Cited by 455
Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10
Chang, S., Young, B. D., Li, S., Qi, X., Richardson, J. A., & Olson, E. N. (2006) · Cell · doi:10.1016/j.cell.2006.05.040 · Cited by 453
Yang, W.-M., Yao, Y.-L., Sun, J.-M., Davie, J. R., & Seto, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28001 · Cited by 438
Regulation of Transcription Factor YY1 by Acetylation and Deacetylation
Yao, Y.-L., Yang, W.-M., & Seto, E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5979-5991.2001 · Cited by 434
Histone Deacetylases Specifically Down-regulate p53-dependent Gene Activation
Juan, L.-J., Shia, W.-J., Chen, M.-H., Yang, W.-M., Seto, E., Lin, Y.-S., & Wu, C.-W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000202200 · Cited by 419
Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication
Yang, X.-J., & Grégoire, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.2873-2884.2005 · Cited by 419
HIV-1 Tat transcriptional activity is regulated by acetylation
Kiernan, R. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.6106 · Cited by 416
An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function
Scroggins, B. T., Robzyk, K., Wang, D., Marcu, M. G., Tsutsumi, S., Beebe, K., Cotter, R. J., Felts, S., Toft, D., Karnitz, L., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.008 · Cited by 413
Deroanne, C. F., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J.-M., Nusgens, B. V., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205108 · Cited by 400
Histone deacetylase 8 in neuroblastoma tumorigenesis
Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0684 · Cited by 398
Control of Smad7 Stability by Competition between Acetylation and Ubiquitination
Grönroos, E., Hellman, U., Heldin, C.-H., & Ericsson, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00639-1 · Cited by 383
Posttranslational modification and microtubule stability.
Schulze, E., Asai, D. J., Bulinski, J. C., & Kirschner, M. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.5.2167 · Cited by 372
HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates
Boyault, C., Zhang, Y., Fritah, S., Caron, C., Gilquin, B., Kwon, S. H., Garrido, C., Yao, T.-P., Vourc’h, C., Matthias, P., et al. (2007) · Genes & Development · doi:10.1101/gad.436407 · Cited by 368
Acetylation of MyoD Directed by PCAF Is Necessary for the Execution of the Muscle Program
Sartorelli, V., Puri, P. L., Hamamori, Y., Ogryzko, V., Chung, G., Nakatani, Y., Wang, J. Y. J., & Kedes, L. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80383-4 · Cited by 356
Regulation of histone deacetylase activities
Sengupta, N., & Seto, E. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20179 · Cited by 346
Huang, B. H., Laban, M., Leung, C. H.-W., Lee, L., Lee, C. K., Salto-Tellez, M., Raju, G. C., & Hooi, S. C. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401567 · Cited by 337
Nα-terminal Acetylation of Eukaryotic Proteins
Polevoda, B., & Sherman, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000023200 · Cited by 337
Acetylation of HMG I(Y) by CBP Turns off IFNβ Expression by Disrupting the Enhanceosome
Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G., & Thanos, D. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80145-8 · Cited by 321
DNA Damage-Dependent Acetylation of p73 Dictates the Selective Activation of Apoptotic Target Genes
Costanzo, A., Merlo, P., Pediconi, N., Fulco, M., Sartorelli, V., Cole, P. A., Fontemaggi, G., Fanciulli, M., Schiltz, L., Blandino, G., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00431-8 · Cited by 319
Wade, P. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.693 · Cited by 317
Ma, H., Nguyen, C., Lee, K.-S., & Kahn, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208433 · Cited by 307
Qian, D. Z., Kachhap, S. K., Collis, S. J., Verheul, H. M. W., Carducci, M. A., Atadja, P., & Pili, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4598 · Cited by 299
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate
Knights, C. D., Catania, J., Giovanni, S. D., Muratoglu, S., Perez, R., Swartzbeck, A., Quong, A. A., Zhang, X., Beerman, T., Pestell, R. G., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512059 · Cited by 287
Acetylation control of the retinoblastoma tumour-suppressor protein
Chan, H. M., Krstic-Demonacos, M., Smith, L., Demonacos, C., & Thangue, N. B. L. (2001) · Nature Cell Biology · doi:10.1038/35083062 · Cited by 282
HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions
Tran, A. D.-A., Marmo, T. P., Salam, A. A., Che, S., Finkelstein, E., Kabarriti, R., Xenias, H. S., Mazitschek, R., Hubbert, C., Kawaguchi, Y., et al. (2007) · Journal of Cell Science · doi:10.1242/jcs.03431 · Cited by 281
Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity
Ott, M., Schnölzer, M., Garnica, J., Fischle, W., Emiliani, S., Rackwitz, H.-R., & Verdin, E. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80120-7 · Cited by 278
Zhao, Y., Lu, S., Wu, L., Chai, G., Wang, H., Chen, Y., Sun, J., Yu, Y., Zhou, W., Zheng, Q., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2782-2790.2006 · Cited by 277
The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
Lee, Y.-S., Lim, K.-H., Guo, X., Kawaguchi, Y., Gao, Y., Barrientos, T., Ordentlich, P., Wang, X.-F., Counter, C. M., & Yao, T.-P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0188 · Cited by 260
Kong, X., Lin, Z., Liang, D., Fath, D., Sang, N., & Caro, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2019-2028.2006 · Cited by 258
Histone deacetylase as a therapeutic target
Krämer, O. H., Göttlicher, M., & Heinzel, T. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00438-6 · Cited by 257
Druesne, N. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh123 · Cited by 254
Histone deacetylase inhibitors: Signalling towards p21cip1/waf1
Ocker, M., & Schneider-Stock, R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.001 · Cited by 250
Steele, N. L., Plumb, J. A., Vidal, L., Tjørnelund, J., Knoblauch, P., Rasmussen, A., Ooi, C. E., Buhl-Jensen, P., Brown, R., Evans, T. R. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1786 · Cited by 244
Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review
Acharya, M. R., Sparreboom, A., Venitz, J., & Figg, W. D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014167 · Cited by 235
E2F Family Members Are Differentially Regulated by Reversible Acetylation
Marzio, G., Wagener, C., Gutierrez, M. I., Cartwright, P., Helin, K., & Giacca, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10887 · Cited by 231
Qian, D. Z., Wang, X., Kachhap, S. K., Kato, Y., Wei, Y., Zhang, L., Atadja, P., & Pili, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0540 · Cited by 229
Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical Trials
Ma, X., Ezzeldin, H. H., & Diasio, R. B. (2009) · Drugs · doi:10.2165/11315680-000000000-00000 · Cited by 227
Valproic Acid Inhibits Angiogenesis in Vitro and in Vivo
Michaelis, M., Michaelis, U. R., Fleming, I., Suhan, T., Cinatl, J., Blaheta, R. A., Hoffmann, K., Kotchetkov, R., Busse, R., Nau, H., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.520 · Cited by 227
Regulation of protein turnover by acetyltransferases and deacetylases
Sadoul, K., Boyault, C., Pabion, M., & Khochbin, S. (2008) · Biochimie · doi:10.1016/j.biochi.2007.06.009 · Cited by 222
Acetylation of Stat1 modulates NF-κB activity
Krämer, O. H., Baus, D., Knauer, S. K., Stein, S., Jäger, E., Stauber, R. H., Grez, M., Pfitzner, E., & Heinzel, T. (2006) · Genes & Development · doi:10.1101/gad.364306 · Cited by 219
Faiola, F., Liu, X., Lo, S., Pan, S., Zhang, K., Lymar, E., Farina, A., & Martinez, E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10220-10234.2005 · Cited by 218
Osada, H., Tatematsu, Y., Saito, H., Yatabe, Y., Mitsudomi, T., & Takahashi, T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20395 · Cited by 213
Chang, H.-M., Paulson, M., Holko, M., Rice, C. M., Williams, B. R. G., Marié, I., & Levy, D. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400567101 · Cited by 212
Dequiedt, F., Kasler, H., Fischle, W., Kiermer, V., Weinstein, M., Herndier, B. G., & Verdin, E. (2003) · Immunity · doi:10.1016/s1074-7613(03)00109-2 · Cited by 212
Acetylation-Dependent Signal Transduction for Type I Interferon Receptor
Tang, X., Gao, J.-S., Guan, Y.-J., McLane, K. E., Yuan, Z.-L., Ramratnam, B., & Chin, Y. E. (2007) · Cell · doi:10.1016/j.cell.2007.07.034 · Cited by 211
Coordination of a Transcriptional Switch by HMGI(Y) Acetylation
Munshi, N., Agalioti, T., Lomvardas, S., Merika, M., Chen, G., & Thanos, D. (2001) · Science · doi:10.1126/science.293.5532.1133 · Cited by 206
Rössig, L., Li, H., Fisslthaler, B., Urbich, C., Fleming, I., Förstermann, U., Zeiher, A. M., & Dimmeler, S. (2002) · Circulation Research · doi:10.1161/01.res.0000037983.07158.b1 · Cited by 198
HDAC6 Deacetylase Activity Links the Tubulin Cytoskeleton with Immune Synapse Organization
Serrador, J. M., Cabrero, J. R., Sancho, D., Mittelbrunn, M., Urzainqui, A., & Sánchez-Madrid, F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00078-0 · Cited by 193
Requirement of Histone Deacetylase Activity for Signaling by STAT1
Klampfer, L., Huang, J., Swaby, L.-A., & Augenlicht, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401359200 · Cited by 189
The Balance between Acetylation and Deacetylation Controls Smad7 Stability
Simonsson, M., Heldin, C.-H., Ericsson, J., & Grönroos, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503134200 · Cited by 186
Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma
Sakuma, T., Uzawa, K., Onda, T., Shiiba, M., Yokoe, H., Shibahara, T., & Tanzawa, H. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.1.117 · Cited by 185
Zhang, W., Kadam, S., Emerson, B. M., & Bieker, J. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.7.2413-2422.2001 · Cited by 182
Genetic dissection of glucocorticoid receptor function in mice
Tronche, F., Kellendonk, C., Reichardt, H. M., & Schütz, G. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80007-5 · Cited by 180
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
McMahon, C., Suthiphongchai, T., DiRenzo, J., & Ewen, M. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5382 · Cited by 178
Chemoprotection by sulforaphane: Keep one eye beyond Keap1
Myzak, M. C., & Dashwood, R. H. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.02.033 · Cited by 173
PTEN Acetylation Modulates Its Interaction with PDZ Domain
Ikenoue, T., Inoki, K., Zhao, B., & Guan, K.-L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1107 · Cited by 168
Galasinski, S. C., Resing, K. A., Goodrich, J. A., & Ahn, N. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201174200 · Cited by 164
HDACi – Targets beyond chromatin
Buchwald, M., Krämer, O. H., & Heinzel, T. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.028 · Cited by 159
Sterner, R., Vidali, G., & Allfrey, V. G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86524-9 · Cited by 156
Zhao, X., Ito, A., Kane, C. D., Liao, T.-S., Bolger, T. A., Lemrow, S. M., Means, A. R., & Yao, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105086200 · Cited by 149
Deng, W., Zhu, Y., & Wu, K. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209286200 · Cited by 146
Shankaranarayanan, P., Chaitidis, P., Kühn, H., & Nigam, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102626200 · Cited by 146
The multiple activities of CtBP/BARS proteins: the Golgi view
Corda, D., Colanzi, A., & Luini, A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.01.007 · Cited by 145
Dowdy, S. C., Jiang, S., Zhou, X., Hou, X., Jin, F., Podratz, K. C., & Jiang, S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0209 · Cited by 143
Self-citationXiong, Y., Dowdy, S. C., Podratz, K. C., Jin, F., Attewell, J. R., Eberhardt, N. L., & Jiang, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2843 · Cited by 139
Self-citationCREB-binding Protein/p300 Activates MyoD by Acetylation
Polesskaya, A., Duquet, A., Naguibneva, I., Weise, C., Vervisch, A., Bengal, E., Hucho, F., Robin, P., & Harel‐Bellan, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003815200 · Cited by 131
Acetylation of adenovirus E1A regulates binding of the transcriptional corepressor CtBP
Zhang, Q., Yao, H. W., Vo, N., & Goodman, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011283598 · Cited by 131
Histone deacetylase 3 associates with and represses the transcription factor GATA-2
Ozawa, Y., Towatari, M., Tsuzuki, S., Hayakawa, F., Maeda, T., Miyata, Y., Tanimoto, M., & Saito, H. (2001) · Blood · doi:10.1182/blood.v98.7.2116 · Cited by 121
Rampalli, S., Chavali, P. L., Bhatt, A., Kundu, T. K., & Chattopadhyay, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8415-8429.2005 · Cited by 120
Johnson, C. A., White, D. A., Lavender, J. S., O'Neill, L. P., & Turner, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107942200 · Cited by 119
Wang, L. G. (1992) · International Journal of Oncology · doi:10.3892/ijo_00000018 · Cited by 118
Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues
He, W., Li, A. G., Wang, D., Han, S., Zheng, B., Goumans, M., ten Dijke, P., & Wang, X. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2580 · Cited by 117
Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65
Buerki, C., Rothgiesser, K., Valovka, T., Owen, H. R., Rehrauer, H., Fey, M., Lane, W. S., & Hottiger, M. O. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn003 · Cited by 116
Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer
Botrugno, O. A., Santoro, F., & Minucci, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.027 · Cited by 114
Regulation of human SRY subcellular distribution by its acetylation/deacetylation
Thevenet, L., Méjean, C., Moniot, B., Bonneaud, N., Galéotti, N., Aldrian, G., Poulat, F., Berta, P., Benkirane, M., & Boizet‐Bonhoure, B. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600352 · Cited by 114
Bandyopadhyay, D., Mishra, A., & Medrano, E. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3897 · Cited by 110
Marrocco, D. L., Tilley, W. D., Bianco‐Miotto, T., Evdokiou, A., Scher, H. I., Rifkind, R. A., Marks, P. A., Richon, V. M., & Butler, L. M. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0144 · Cited by 109
Sirt2 interacts with 14-3-3 β/γ and down-regulates the activity of p53
Jin, Y.-H., Kim, Y.-J., Kim, D., Baek, K., Kang, B. Y., Yeo, C., & Lee, K.-Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.114 · Cited by 103
Functional regulation of GATA-2 by acetylation
Hayakawa, F., Towatari, M., Ozawa, Y., Tomita, A., Privalsky, M. L., & Saito, H. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603389 · Cited by 103
Acetylation of Sirt2 by p300 attenuates its deacetylase activity
Han, Y., Jin, Y.-H., Kim, Y.-J., Kang, B. Y., Choi, H.-J., Kim, D., Yeo, C., & Lee, K.-Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.042 · Cited by 101
The Flavoring Agent Dihydrocoumarin Reverses Epigenetic Silencing and Inhibits Sirtuin Deacetylases
Olaharski, A. J., Rine, J., Marshall, B. L., Babiarz, J., Zhang, L., Verdin, E. M., & Smith, M. T. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010077 · Cited by 99
Hahn, C. K., Ross, K. N., Warrington, I. M., Mazitschek, R., Kanegai, C. M., Wright, R. D., Kung, A. L., Golub, T. R., & Stegmaier, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710413105 · Cited by 97
Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?
Karagiannis, T. C., & El‐Osta, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404464 · Cited by 96
Specific Acetylation of Chromosomal Protein HMG-17 by PCAF Alters Its Interaction with Nucleosomes
Herrera, J. E., Sakaguchi, K., Bergel, M., Trieschmann, L., Nakatani, Y., & Bustin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3466 · Cited by 93
Jacob, A. L. J., Lund, J., Martínez, P., & Hedin, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104427200 · Cited by 91
The Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity
Fu, M., Rao, M., Wu, K., Wang, C., Zhang, X., Hessien, M., Yeung, Y.-G., Gioeli, D. G., Weber, M. J., & Pestell, R. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313466200 · Cited by 91
Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.
Ju, R., & Muller, M. T. (2003) · PubMed · Cited by 85
Madison, D. L., Yaciuk, P., Kwok, R. P. S., & Lundblad, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207512200 · Cited by 83
Parra, M., Mahmoudi, T., & Verdin, E. M. (2007) · Genes & Development · doi:10.1101/gad.1513107 · Cited by 80
Unanticipated Repression Function Linked to Erythroid Krüppel-Like Factor
Chen, X., & Bieker, J. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3118-3125.2001 · Cited by 77
Das, C., & Kundu, T. K. (2005) · IUBMB Life · doi:10.1080/15216540500090629 · Cited by 73
Stage-Specific Repression by the EKLF Transcriptional Activator
Chen, X., & Bieker, J. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10416-10424.2004 · Cited by 71
Undevia, S. D., Kindler, H. L., Janisch, L. A., Olson, S. C., Schilsky, R. L., Vogelzang, N. J., Kimmel, K. A., Macek, T. A., & Ratain, M. J. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh438 · Cited by 71
Sargeant, A. M., Rengel, R. C., Kulp, S. K., Klein, R. D., Clinton, S. K., Wang, Y.-C., & Chen, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0203 · Cited by 70
In Vitro Acetylation of HMGB-1 and -2 Proteins by CBP: the Role of the Acidic Tail
Pasheva, E. A., Sarov, M., Bidjekov, K., Ugrinova, I., Sarg, B., Lindner, H. H., & Pashev, I. G. (2004) · Biochemistry · doi:10.1021/bi035615y · Cited by 69
Yao, X., & Nyomba, B. L. G. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00804.2007 · Cited by 69
Bergel, M., Herrera, J. E., Thatcher, B. J., Prymakowska-Bosak, M., Vassilev, A. P., Nakatani, Y., Martin, B., & Bustin, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11514 · Cited by 68
Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells
Januchowski, R., Dąbrowski, M., Ofori, H., & Jagodziński, P. P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.03.010 · Cited by 65
Explorative Study on Isoform-Selective Histone Deacetylase Inhibitors
Suzuki, T. (2009) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.57.897 · Cited by 63
Autoregulation of Mouse Histone Deacetylase 1 Expression
Schuettengruber, B., Simboeck, E., Khier, H., & Seiser, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.6993-7004.2003 · Cited by 63
DNA‐damage‐responsive acetylation of pRb regulates binding to E2F‐1
Markham, D., Munro, S., Soloway, J., O'Connor, D. P., & La Thangue, N. B. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400591 · Cited by 62
Schneider‐Stock, R., & Ocker, M. (2007) · PubMed · Cited by 61
General Transcriptional Coactivator PC4 Activates p53 Function
Banerjee, S., Kumar, B. R. P., & Kundu, T. K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2052-2062.2004 · Cited by 60
p300-mediated Acetylation of Human Transcriptional Coactivator PC4 Is Inhibited by Phosphorylation
Kumar, B. R. P., Swaminathan, V., Banerjee, S., & Kundu, T. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100934200 · Cited by 56
Reversible acetylation of non histone proteins: role in cellular function and disease.
Batta, K., Das, C., Gadad, S. S., Shandilya, J., & Kundu, T. K. (2007) · PubMed · Cited by 55
SHP Represses Transcriptional Activity via Recruitment of Histone Deacetylases
Gobinet, J., Carascossa, S., Cavaillès, V., Vignon, F., Nicolas, J., & Jalaguier, S. (2005) · Biochemistry · doi:10.1021/bi047308d · Cited by 51
Forced Evolution of a Regulatory RNA Helix in the HIV-1 Genome
Berkhout, B., Klaver, B., & Das, A. T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.5.940 · Cited by 51
Lin, H., Hopkins, R. L., Cao, H., Tang, H., ALEXANDER, C., DAVIS, F., & Davis, P. J. (2005) · Steroids · doi:10.1016/j.steroids.2005.03.001 · Cited by 50
Acetylation regulates subcellular localization of the Wnt signaling nuclear effector POP-1Preprint
Gay, F., Calvo, D., Lo, M., Cerón, J., Maduro, M., Lin, R., & Shi, Y. (2003) · Genes & Development · doi:10.1101/gad.1042403 · Cited by 50
Regulation of SV40 large T-antigen stability by reversible acetylation
Shimazu, T., Komatsu, Y., Nakayama, K. I., Fukazawa, H., Horinouchi, S., & Yoshida, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209731 · Cited by 49
Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells
Santos, M. J. D. L., Martínez-Iglesias, O. A., & Aranda, A. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0144 · Cited by 48
Deng, Q., Li, Y., Tedesco, D., Liao, R., Fuhrmann, G., & Sun, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0054 · Cited by 46
Reversible Acetylation Of Non Histone Proteins: Role in cellular function and disease
Batta, K., Das, C., Gadad, S. S., Shandilya, J., & Kundu, T. K. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5466-1_9 · Cited by 46
Lu, Q., Lin, X., Feng, J., Zhao, X., Gallagher, R., Lee, M. Y., Chiao, J.-W., & Liu, D. (2008) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-1-6 · Cited by 45
Rausa, F. M., Hughes, D. E., & Costa, R. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407472200 · Cited by 45
Chaperoning steroid hormone signaling via reversible acetylation
Kovacs, J. J., Cohen, T. J., & Yao, T. (2005) · Nuclear Receptor Signaling · doi:10.1621/nrs.03004 · Cited by 39
When Pol I Goes into High Gear: Processive DNA Synthesis by Pol I in the Cell
Camps, M., & Loeb, L. A. (2004) · Cell Cycle · doi:10.4161/cc.3.2.651 · Cited by 38
ARDent about acetylation and deacetylation in hypoxia signalling
Bilton, R. L., Trottier, E., Pouysségur, J., & Brahimi-Horn, M. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.10.002 · Cited by 34
Gabrielli, B. G., Johnstone, R. W., & Saunders, N. A. (2002) · Current Cancer Drug Targets · doi:10.2174/1568009023333818 · Cited by 33
Application of DNA methylation biomarkers for endometrial cancer management
Jiang, S., Li, J., Podratz, K. C., & Dowdy, S. C. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.5.607 · Cited by 33
Self-citationKawai, H., Yamada, Y., Tatsuka, M., Niwa, O., Yamamoto, K., & Suzuki, F. (1999) · PubMed · Cited by 28
Lührs, H., Hock, R., Schauber, J., Weihrauch, M., Harrer, M., Melcher, R., Scheppach, W. M., Bustin, M., & Menzel, T. (2001) · International Journal of Cancer · doi:10.1002/ijc.10098 · Cited by 25
Promising antitumor activity with MGCD0103, a novel isotype-selective histone deacetylase inhibitor
Tourneau, C. L., & Siu, L. L. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.8.1247 · Cited by 24
Sodium butyrate modifies the stabilizing complexes of tyrosine hydroxylase mRNA
Arányi, T., Sarkis, C., Berrard, S., Sardin, K., Siron, V., Khalfallah, O., & Mallet, J. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.025 · Cited by 17
Structure of the Hepatocyte Nuclear Factor 6α and Its Interaction with DNA
Sheng, W., Yan, H., Rausa, F. M., Costa, R. H., & Liao, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403805200 · Cited by 17
Warnock, L. J., Raines, S. A., Mee, T. R., & Milner, J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04589.x · Cited by 13
Cited by
Singh, B. N., Shankar, S., & Srivastava, R. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.093 · Cited by 1,602
Self-citationHistone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
Mottamal, M., Zheng, S., Huang, T., & Wang, G. (2015) · Molecules · doi:10.3390/molecules20033898 · Cited by 680
Epigenetic modifications of histones in cancer
Zhao, Z., & Shilatifard, A. (2019) · Genome Biology · doi:10.1186/s13059-019-1870-5 · Cited by 552
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Critical roles of non-histone protein lysine methylation in human tumorigenesis
Hamamoto, R., Saloura, V., & Nakamura, Y. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3884 · Cited by 376
Metadata
- Authors
- Singh, B. N., Zhang, G., Hwa, Y. L., Li, J., Dowdy, S. C., & Jiang, S.-W.
- Venue
- Expert Review of Anticancer Therapy
- Publisher
- Informa UK Limited
- Published
- 2010-06
- Volume
- 10
- Issue
- 6
- Pages
- 935-954
- ISSN
- 1473-7140 (ISSN-L)
- 1744-8328
- OpenAlex
- W2164453551
- Cited by
- 300
- References
- 186
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.